Related Experiment Video
Updated: Feb 7, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Severe upper gastrointestinal disorders in pembrolizumab-treated non-small cell lung cancer patient
Tsugitoshi Onuki1, Eri Morita1, Noritaka Sakamoto1
1Division of Pulmonary Medicine, Department of Internal Medicine Jichi Medical University Shimotsuke Japan.
Abstract:
Pembrolizumab is an immune checkpoint inhibitor that induces side effects called "immune-related adverse events" (irAEs). Various types of organs are affected by irAEs, although reports of upper gastrointestinal disorders are rare. Here, we report a case of extensive inflammatory pathologies in the oesophagus, stomach, duodenum, and jejunum after the administration of pembrolizumab for non-small cell lung cancer.
More Related Videos
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
06:49Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Related Concept Videos
Gastrointestinal Motility Disorders
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Anatomy of the Gastrointestinal System
Here's a detailed walkthrough of this complex system:
Intrinsically Disordered Proteins
Lung Capacity
Arteries of the Upper Limbs